DEBT CONVERSION AGREEMENTDebt Conversion Agreement • March 15th, 2022 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of October 8, 2021 by and between Bone Biologics Corporation, a Delaware corporation (the “Company”), and Hankey Capital, LLC (“Purchaser”).
SUPPLY AND DEVELOPMENT SUPPORT AGREEMENT by and between BONE BIOLOGICS CORPORATION and MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. Dated as of March 3, 2022Supply and Development Support Agreement • March 15th, 2022 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New Jersey
THIS SUPPLY and DEVELOPMENT SUPPORT AGREEMENT (this “Agreement”), dated as of the 3rd day of March, 2022 (“Effective Date”), is made and entered into by and between BONE BIOLOGICS CORPORATION, a corporation organized under the laws of the State of Delaware, and having a principal place of business at 2 Burlington Woods Drive, Suite 100, Burlington, Massachusetts 01803 (“BBC”), and MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., a District of Columbia non-profit corporation, with its principal place of business at 125 May Street, Suite 300, Edison, New Jersey 08837 (“MTF”).
